Team Against Opioid Abuse Site Launched

The website, launched by Purdue Pharma, LP, aims to educate healthcare providers and patients about abuse- deterrent opioid-based painkillers. Purdue markets two of the three opioid formulations available with the abuse- deterrent properties. The site features sections about why it’s critical to deter abuse and how all the members on the healthcare team can make a difference. It also outlines the 2015 Food & Drug Administration’s Guidance on Abuse-Deterrent Opioids — Evaluation and Labeling, which informs drug developers about FDA’s current thinking on what kinds of testing potentially abuse-deterrent opioids should undergo. Because FDA states that having information about an opioid’s abuse deterrence available for healthcare professionals and patients, the website also reviews how Section 9.2 of a drug product’s Full Prescribing Information is the key to identifying opioid formulations with FDA-approved abuse-deterrent properties. “We dev eloped this website to inform everybody who influences how drugs are prescribed, taken, stored, and destroyed when no longer needed,” stated Dr. J. David Haddox, vice president of health policy at Purdue.